These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 14765474)

  • 1. HIV vaccines: current challenges and future directions.
    Avrett S; Collins C
    Can HIV AIDS Policy Law Rev; 2002 Jul; 7(1):1, 20-5. PubMed ID: 14765474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barcelona 2002: law, ethics, and human rights. Advancing research and access to HIV vaccines: a framework for action.
    Avrett S
    Can HIV AIDS Policy Law Rev; 2002 Dec; 7(2-3):101-5. PubMed ID: 14743820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global access to treatment: achievements and challenges.
    Cameron E; Gupta A
    Can HIV AIDS Policy Law Rev; 2002 Jul; 7(1):59-71. PubMed ID: 14765514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug policy in Canada--the way forward.
    Kerr T; O'Briain W
    Can HIV AIDS Policy Law Rev; 2002 Jul; 7(1):1, 27-32. PubMed ID: 14765475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-related stigma and discrimination--the epidemic continues.
    de Bruyn T
    Can HIV AIDS Policy Law Rev; 2002 Jul; 7(1):8-14. PubMed ID: 14765477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV treatments, vaccines, and microbicides: toward coordinated advocacy.
    Godwin J
    Can HIV AIDS Policy Law Rev; 2004 Apr; 9(1):1, 7-14. PubMed ID: 15216806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resolving legal, ethical, and human rights challenges in HIV vaccine research.
    Patterson D
    Can HIV AIDS Policy Law Rev; 2000; 5(4):60-6. PubMed ID: 11833175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost effectiveness and delivery study for future HIV vaccines.
    Barth-Jones DC; Cheng H; Kang LY; Kenya PR; Odera D; Mosqueira NR; Mendoza W; Portela MC; Brito C; Tangcharoensathien V; Akaleephan C; Supantamart S; Patcharanarumol W; de Macedo Brigido LF; Fonseca MG; Sanchez M; Chang ML; Osmanov S; Avrett S; Esparza J; Griffiths U;
    AIDS; 2005 Sep; 19(13):w1-6. PubMed ID: 16103763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Public health considerations for the use of a first generation HIV vaccine. Report from a WHO-UNAIDS-CDC consultation, Geneva, 20-21 November 2002.
    Chang ML; Vitek C; Esparza J;
    AIDS; 2003 Oct; 17(15):W1-10. PubMed ID: 14523295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Convergent ethical issues in HIV/AIDS, tuberculosis and malaria vaccine trials in Africa: Report from the WHO/UNAIDS African AIDS Vaccine Programme's Ethics, Law and Human Rights Collaborating Centre consultation, 10-11 February 2009, Durban, South Africa.
    Mamotte N; Wassenaar D; Koen J; Essack Z
    BMC Med Ethics; 2010 Mar; 11():3. PubMed ID: 20211030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Putting third first: critical legal issues and HIV/AIDS.
    Can HIV AIDS Policy Law Rev; 2000; 5(4):54-7. PubMed ID: 11833173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerating the development of an AIDS vaccine: the AIDS vaccine for Asia Network (Avan).
    Pitisuttithum P; Rerks-Ngarm S; Chiu J; Kim J; Benenson M; Kent SJ; Tamashiro H; Manrique A; Bernstein A; Goyal R; Ditangco RA; Cooper DA; Osmanov S; Mathieson B; Sandstrom E; Esparza J; Hoff R; Shao Y;
    Southeast Asian J Trop Med Public Health; 2011 Sep; 42(5):1130-46. PubMed ID: 22299439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expert meeting on HIV vaccine research, development, and access.
    Can HIV AIDS Policy Law Rev; 2002 Jul; 7(1):43-4. PubMed ID: 14765498
    [No Abstract]   [Full Text] [Related]  

  • 14. Transcalar networks for policy transfer and implementation: the case of global health policies for malaria and HIV/AIDS in Cameroon.
    Ngoasong MZ
    Health Policy Plan; 2011 Jan; 26(1):63-72. PubMed ID: 20494940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating the demand for a preventive HIV vaccine: why we need to do better. Reliable estimates would help in achieving several policy and advocacy objectives.
    Hecht R; Suraratdecha C
    PLoS Med; 2006 Sep; 3(10):e398. PubMed ID: 16953657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy trials for HIV/AIDS vaccines.
    Petricciani JC; Koff WC; Ada GL
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1527-9. PubMed ID: 1466997
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of policy in community pharmacies' response to injection-drug use: results of a nationwide Canadian survey.
    Myers T; Cockerill R; Millson M; Rankin J; Worthington C
    AIDS Public Policy J; 1996; 11(2):78-88. PubMed ID: 10915241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Legal and ethical issues in microbicides research and development in Canada.
    Alexandrova A
    Can HIV AIDS Policy Law Rev; 2004 Aug; 9(2):39-42. PubMed ID: 15540344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advocacy group sees little progress toward an HIV vaccine.
    AIDS Policy Law; 1998 May; 13(10):1, 8-9. PubMed ID: 11365444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Public-private partnerships for equity of access to care for tuberculosis and HIV/AIDS: lessons from Pune, India.
    Sheikh K; Porter J; Kielmann K; Rangan S
    Trans R Soc Trop Med Hyg; 2006 Apr; 100(4):312-20. PubMed ID: 16438997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.